Skip to content

Phase I Study of Plitidepsin Administered Intravenously as a Single Dose in Healthy Volunteers

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2024-513664-25-00
Acronym
HV-APL-A-001-24
Enrollment
60
Registered
2025-03-10
Start date
2026-01-26
Completion date
Unknown
Last updated
2026-01-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Virus diseases

Interventions

None listed

Sponsors

Pharma Mar S.A.
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
All
Age
18 Years to 64 Years

Countries

Spain

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026